Phase II Study of Irinotecan in Combination with Capecitabine on a 3-Weekly Schedule as First-Line Chemotherapy for Patients with Metastatic or Locally Advanced Colorectal Cancer. Journal of Analytical Oncology, [S. l.], v. 2, n. 3, p.  151–159, 2013. DOI: 10.6000/1927-7229.2013.02.03.4. Disponível em: https://mail.neoplasiaresearch.com/index.php/jao/article/view/80. Acesso em: 10 oct. 2025.